Using Sema4D-deficient LDLR-/- mice, Zhu et al. (2007, 2009) investigated whether eliminating Sema4D-dependent events could provide a means of platelet hyperactivity reduction in the setting of dyslipidemia. This evidence concerns the gene SEMA4D and metabolic syndrome.